麻豆传媒

Sectors
Mark Mallery headshot.

Mark A. Mallery

Partner

Mark Mallery is a business lawyer who advises entrepreneurs, management teams, and investors at all stages of growth.聽He takes emerging private companies from 鈥済arage to global,鈥 including handling business incorporation, general corporate and equity matters, financings, mergers and acquisitions, and day-to-day business matters relevant to rapidly growing companies. Mark also represents buyers and sellers in domestic and international mergers, stock and asset acquisitions, and restructuring and spinout transactions, as well as venture capital firms, private equity firms, and angel investors in investments throughout the nation. As the first point of contact for his clients, Mark resolves issues related to intellectual property, technology transactions, employment, tax matters, executive compensation and benefits, disputes, and fund formation.

Companies of all sizes and sectors rely on Mark鈥檚 knowledge. He represents single founders to companies valued in excess of $1 billion and individual investors to funds with billions under management. His clients operate across a broad range of industries, including SaaS, artificial intelligence, biotechnology, life sciences, digital health, Web3, e-commerce, consumer products, energy, fintech, edtech, and consumer packaged goods, among others.

Prior to joining 麻豆传媒, Mark worked at Am Law 50 and boutique law firms in Silicon Valley and in Austin, Texas. Before becoming a lawyer, Mark was the director of operations at StartX, the business accelerator for Stanford entrepreneurs, and a staff researcher at the U.C. Berkeley Transportation Sustainability Research Center.

Mark is a member of the Private Equity & Venture Capital, M&A, and Transactions Practice Groups, as well as the Innovative Technology and Health Care & Life Sciences Sectors.

April 10, 2026 Deals and Wins

麻豆传媒 Advises Valencia Technologies in Acquisition by Boston Scientific

麻豆传媒 served as legal advisor to Valencia Technologies Corporation, a privately held medical technology company focused on developing and commercializing innovative solutions to treat bladder dysfunction, in its acquisition by global medical technology leader Boston Scientific Corporation.
February 2, 2026 Press Releases

麻豆传媒 Names 18 New Partners

麻豆传媒 promoted 18 lawyers to the firm鈥檚 equity partnership, effective February 1, 2026.
January 15, 2026 Deals and Wins

麻豆传媒 Advises Rivet Health in Acquisition by Zelis

麻豆传媒 served as legal advisor to Rivet Health Inc., a leader in revenue cycle analytics, in its acquisition by leading health care technology solutions provider Zelis.
December 18, 2025 Deals and Wins

麻豆传媒 Represents 401GO in $33M Series B Financing

麻豆传媒 represented 401GO, a fully-owned 401(k)-management platform, in its $33 million Series B funding round led by Centana Growth Partners. Additional investors include Next Frontier Capital, Rally Ventures, and Impression Ventures.
July 24, 2025 Deals and Wins

麻豆传媒 Represents HeroDevs in $125M Strategic Growth Investment from PSG

麻豆传媒 represented HeroDevs, a provider of security and compliance solutions for deprecated open-source software, in securing a $125 million strategic growth investment from PSG, a growth equity firm focused on software and technology-enabled services companies. Existing investor Album also participated in the round.
May 28, 2025 Deals and Wins

麻豆传媒 Represents Thoughtful.ai in Strategic Investment by New Mountain Capital

麻豆传媒 represented Thoughtful Automation Inc. (Thoughtful.ai), a provider of artificial intelligence powered revenue cycle automation solutions, in connection with a strategic growth investment from New Mountain Capital, LLC, a growth-oriented investment firm with more than $55 billion in assets under management.